Daken: Dark Wolverine
Nearly a month after Marvel Editor-in-Chief Axel Alonso revealed to Comic Book Resources that Daken: Dark Wolverine would be coming to an end, the publisher has set March’s Issue 23 as the series finale.
The first-look X-Men solicitations on the Marvel website list double-shipped Issues 22 and 23, by Rob Williams and Alessandro Vitti, and tease: “Daken’s Terminal Disease Is In Its Final Stages. What Choices Will He Makes When Finally Faced With Death? Will He Die Here And What Will His Final Actions Be?” and “The Final Confrontation Between Daken And His Father, Wolverine.”
The son of Wolverine, Daken was introduced in 2007 in Wolverine Origins #10, before going on to play a prominent role in the “Dark Reign” spinoff Dark Avengers and becoming the lead in Wolverine, retitled Dark Wolverine in June 2009 with Issue 75. That series ended with Issue 90, only to be relaunched in September 2010 as Daken: Dark Wolverine. Although the title had a solid debut, selling more than 48,000 copies, Daken saw a steady loss in readership; November’s Issue 17 sold 18,794 copies, according to estimates by ICv2.com.
The end of Daken: Dark Wolverine in March follows the conclusions of of PunisherMAX and Black Panther: The Most Dangerous Man Alive, and the cancellations of Ghost Rider, X-23, Alpha Flight, Victor Von Doom, Destroyers, Iron Man 2.0 and All-Winners Squad.
Welcome to Food or Comics?, where every week we talk about what comics we’d buy at our local comic shop based on certain spending limits — $15 and $30 — as well as what we’d get if we had extra money or a gift card to spend on a “Splurge” item.
If I had $15, I’d get one from almost every box–Image’s Invincible #85 ($2.99), DC’s DMZ #71 ($2.99), Marvel’s Wolverine and The X-Men #2 ($3.99) and independent title RASL #12 ($3.50). Not much to say about any of these I haven’t already said, except anytime Cory Walker draws a book I’d pay twice cover price.
If I had $30, I’d sneak out of Thanksgiving preparations to first get a book I was surprised I liked as much as I did, despite the last issue’s ending: Shade #2 (DC, $2.99). One thing I wasn’t amped to see was Deathstroke, but given James Robinson and Cully Hammer’s track record I’ll give them the benefit of the doubt. Next up would be the epic (in my mind, at least) team-up of Warren Ellis and Michael Lark on Secret Avengers #19 (Marvel, $3.99). Seeing Ellis boil down the concept into “Run the mission. Don’t get seen. Save the world.” Hits me right between the eyes, and this new issue’s preview has be salivating over it. Last up, I’d pay the giant size price tag for Fantastic Four #600 (Marvel, $7.99) although my patience has worn a little thin with ending the series then bringing it back for #600.
In a just-published interview with Comic Book Resources, Marvel Editor-in-Chief Axel Alonso revealed Daken: Dark Wolverine will be coming to an end, following a wave of cancellations that includes X-23 and Ghost Rider.
Although he didn’t indicate when the series will conclude, February’s Issue 21 is billed as “Issue one of the story the series has been leading up to,” suggesting the beginning of the final arc.
Addressing recent cancellations in this week’s “Axel-in-Charge” column, Alonso told CBR’s Kiel Phegley, “It’s always disappointing when a title comes to an end. I’ll bet everyone reading this column still mourns the death of a title or two they loved – and wonder why the book didn’t stick. And I guarantee you that as frustrated as a fan might be, there’s a writer, artist and an editor who are even more disappointed. That’s just the way things go sometimes. The market won’t support it.
“That said, I’m proud of X-23’s run,” he continued. “Two successful limited series and an ongoing series ain’t bad. Ditto for Daken [who is also ending his series]. From a supporting role in Wolverine: Origins to the lead of ongoing series that included him slicing Frank Castle to bits – enter Franken-Castle. Both were characters that gained traction in a market that, well, doesn’t really have a great track record of supporting new stuff. And both characters anchored legitimate monthly titles. We don’t do R&D at Marvel. We’ll stick by a title for a while – like we did with Spider-Girl – but there comes a point where that title has to earn, usually sooner than later.”